NL-OMON44098撤回4 期
Multinational study assessing the acceptability and determinants of compliance to HPV vaccination to women in screening ages 25 to 45 years - CoheaHr-WP4
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1) Female aged 30-45 years
- •2) Participated in the national screening program for cervical cancer in 2015
- •3) No previous history of HPV vaccine administration.
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •1) Known history of severe allergic reaction or hypersensitivty to any of the components of Cervarix: Sodium chloride (NaCl), Sodium dihydrogen phosphate dihydrate (NaH2PO4.2 H2O), AS04: 3-O-desacyl-4*- monophosphoryl lipid A (MPL) or Aluminium hydroxide (Al(OH)3)
- •2) Known history of immune-related disorders
- •3) Current acute severe febrile illness, except for minor infections such as a cold, mild upper respiratory infection or low-grade fever. When recovered, the vaccine can be administered
- •4) Administration of immunoglobulin or blood-derived products within 6 months prior to scheduled HPV vaccine first dose
- •5) Current pregnancy (reported), breast-feeding or planning to get pregnant in the coming 12 months.
- •6) Hysterectomized women
研究者
相似试验
进行中（未招募）
1 期
Study in several countries to asess the proportion of adult women (30-45 years) WHO accept to receive the HPV vaccine, the reasons to accept it and how many of these women who receive three doses of the vaccine.MedDRA version: 19.0 Level: LLT Classification code 10008229 Term: Cervical cancer System Organ Class: 100000004864MedDRA version: 19.0 Level: LLT Classification code 10056576 Term: Cervical intraepithelial neoplasia System Organ Class: 100000004872Cervical cancerEUCTR2014-003177-42-DKCatalan Institute of Oncology3,250
进行中（未招募）
1 期
Study in several countries to asess the proportion of adult women (25-45 years) WHO accept to receive the HPV vaccine, the reasons to accept it and how many of these women who receive three doses of the vaccine.MedDRA version: 20.0 Level: LLT Classification code 10008229 Term: Cervical cancer System Organ Class: 100000004864MedDRA version: 20.0 Level: LLT Classification code 10056576 Term: Cervical intraepithelial neoplasia System Organ Class: 100000004872Cervical cancerEUCTR2014-003177-42-SECatalan Institute of Oncology3,250
进行中（未招募）
1 期
Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.MedDRA version: 17.1Level: LLTClassification code 10008229Term: Cervical cancerSystem Organ Class: 100000004864MedDRA version: 17.1Level: LLTClassification code 10056576Term: Cervical intraepithelial neoplasiaSystem Organ Class: 100000004872Cervical cancerEUCTR2014-003177-42-BEGhent University Hospital3,250
进行中（未招募）
1 期
Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.Cervical cancerEUCTR2014-003177-42-SICatalan Institute of Oncology3,250
进行中（未招募）
1 期
Study in several countries to assess the proportion of adult women (25-45 yrs) who accept to receive the HPV vaccine, the reasons to accept it and how many of these women receive the three doses and why.Cervical cancerEUCTR2014-003177-42-FICatalan Institute of Oncology3,648